Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is 11.20x as of the fiscal period ended Monday, September 30, 2024.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
11.20x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+275.74%
vs the sector median at left
Jin Medical International Ltd.
Market Cap
$15.58M
Interest Coverage Ratio
11.20x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.68M
Interest Coverage Ratio
-68.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.30M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.94M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.73M
Interest Coverage Ratio
-1.98x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.52M
Interest Coverage Ratio
-15.67x
TTM Avg
0.81x
3Y Avg
0.81x
5Y Avg
0.81x
Market Cap
$16.64M
Interest Coverage Ratio
-111.88x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.46M
Interest Coverage Ratio
-18.73x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jin Medical International Ltd. (ZJYL) | $15.58M | 11.20x | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | -68.14x | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $15.78M | N/A | N/A | N/A | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | N/A | N/A | N/A | N/A |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.94M | N/A | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.73M | -1.98x | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | -15.67x | 0.81x | 0.81x | 0.81x |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -111.88x | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $14.46M | -18.73x | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | -1288.77x | 51.73x | 51.73x | 51.73x |
Interest Coverage
11.2x
Debt/Equity
0.68
Current Ratio
1.95
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-09-30 | 11.20x |
